Epstein-barr virus-associated gastric carcinoma: A newly defined entity

Journal of Clinical Gastroenterology

Volumn 46, Issue 4, 2012, Pages 262-271

  Chen, Jian Ning ^a   He, Dan ^a   Tang, Fang ^a   Shao, Chun Kui ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

clinicopathologic characteristics; Epstein Barr virus; gastric carcinoma; prognosis

Indexed keywords

BARF1 PROTEIN; EPSTEIN BARR VIRUS ANTIGEN 1; EPSTEIN BARR VIRUS ENCODED SMALL RNA; LATENT MEMBRANE PROTEIN 2; LATENT MEMBRANE PROTEIN 2A; RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AGE DISTRIBUTION; CANCER EPIDEMIOLOGY; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; COPY NUMBER VARIATION; EPIGENETICS; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS ASSOCIATED GASTRIC CARCINOMA; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; MICROSATELLITE INSTABILITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEX RATIO; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE; VIRUS GENE; VIRUS GENOME; VIRUS LATENCY; VIRUS REPLICATION;

CPG ISLANDS; DNA METHYLATION; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HERPESVIRUS 4, HUMAN; HUMANS; MALE; POLYMORPHISM, GENETIC; STOMACH NEOPLASMS;

EID: 84862801280     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318249c4b8     Document Type: Review

References (134)

1. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitts lymphoma. Lancet. 1964;1:702-703.
2. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004;4:757-768. (Pubitemid 39331148)
3. Burke AP, Yen TS, Shekitka KM, et al. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol. 1990;3:377-380.
4. Shibata D, Tokunaga M, Uemura Y, et al. Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol. 1991;139:469-474.
5. Shibata D, Weiss LM. Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol. 1992;140:769-774.
6. Tokunaga M, Land CE, Uemura Y, et al. Epstein-Barr virus in gastric carcinoma. Am J Pathol. 1993;143:1250-1254. (Pubitemid 24057093)
7. Akiba S, Koriyama C, Herrera-Goepfert R, et al. Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features. Cancer Sci. 2008;99:195-201. (Pubitemid 351228470)
8. Lee JH, Kim SH, Han SH, et al. Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis. J Gastroenterol Hepatol. 2009;24:354-365.
9. Uozaki H, Fukayama M. Epstein-Barr virus and gastric carcinoma-viral carcinogenesis through epigenetic mechanisms. Int J Clin Exp Pathol. 2008;1:198-216.
10. Kang GH, Lee S, Kim WH, et al. Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol. 2002;160:787-794. (Pubitemid 34224568)
11. Osawa T, Chong JM, Sudo M, et al. Reduced expression and promoter methylation of p16 gene in Epstein-Barr virusassociated gastric carcinoma. Jpn J Cancer Res. 2002;93: 1195-1200. (Pubitemid 36032981)
12. Ushiku T, Chong JM, Uozaki H, et al. p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer. 2007;120:60-66. (Pubitemid 44901918)
13. Wu MS, Shun CT, Wu CC, et al. Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations. Gastroenterology. 2000;118:1031-1038.
14. Sudo M, Chong JM, Sakuma K, et al. Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer. 2004;109:194-199. (Pubitemid 38240920)
15. van Beek J, zur Hausen A, Klein Kranenbarg E, et al. EBVpositive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J Clin Oncol. 2004;22:664-670. (Pubitemid 41095069)
16. Levine PH, Stemmermann G, Lennette ET, et al. Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr-virus-associated gastric adenocarcinoma. Int J Cancer. 1995;60:642-644.
17. Imai S, Koizumi S, Sugiura M, et al. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA. 1994; 91:9131-9135.
18. Galetsky SA, Tsvetnov VV, Land CE, et al. Epstein-Barrvirus-associated gastric cancer in Russia. Int J Cancer. 1997; 73:786-789.
19. Carrascal E, Koriyama C, Akiba S, et al. Epstein-Barr virusassociated gastric carcinoma in Cali, Colombia. Oncol Rep. 2003;10:1059-1062.
20. Ojima H, Fukuda T, Nakajima T, et al. Infrequent overexpression of p53 protein in Epstein-Barr virus-associated gastric carcinomas. Jpn J Cancer Res. 1997;88:262-266. (Pubitemid 27170486)
21. Abdirad A, Ghaderi-Sohi S, Shuyama K, et al. Epstein-Barr virus associated gastric carcinoma: a report from Iran in the last four decades. Diagn Pathol. 2007;2:25.
22. Alipov G, Nakayama T, Nakashima M, et al. Epstein-Barr virus-associated gastric carcinoma in Kazakhstan. World J Gastroenterol. 2005;11:27-30. (Pubitemid 40090130)
23. Chang MS, Lee HS, Kim CW, et al. Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea. Pathol Res Pract. 2001;197:395-400. (Pubitemid 32544902)
24. Corvalan A, Koriyama C, Akiba S, et al. Epstein-Barr virus in gastric carcinoma is associated with location in the cardia and with a diffuse histology: a study in one area of Chile. Int J Cancer. 2001;94:527-530.
25. Hao Z, Koriyama C, Akiba S, et al. The Epstein-Barr virusassociated gastric carcinoma in southern and northern China. Oncol Rep. 2002;9:1293-1298.
26. Harn HJ, Chang JY, Wang MW, et al. Epstein-Barr virusassociated gastric adenocarcinoma in Taiwan. Hum Pathol. 1995;26:267-271.
27. Herrera-Goepfert R, Reyes E, Hernandez-Avila M, et al. Epstein-Barr virus-associated gastric carcinoma in Mexico: analysis of 135 consecutive gastrectomies in two hospitals. Mod Pathol. 1999;12:873-878. (Pubitemid 29444552)
28. Karim N, Pallesen G. Epstein-Barr virus (EBV) and gastric carcinoma in Malaysian patients. Malays J Pathol. 2003;25:45-47.
29. Kattoor J, Koriyama C, Akiba S, et al. Epstein-Barr virusassociated gastric carcinoma in southern India: a comparison with a large-scale Japanese series. J Med Virol. 2002; 68:384-389.
30. Koriyama C, Akiba S, Iriya K, et al. Epstein-Barr virusassociated gastric carcinoma in Japanese Brazilians and non-Japanese Brazilians in Sao Paulo. Jpn J Cancer Res. 2001;92: 911-917. (Pubitemid 32970430)
31. Lopes LF, Bacchi MM, Elgui-de-Oliveira D, et al. Epstein-Barr virus infection and gastric carcinoma in Sao Paulo State, Brazil. Braz J Med Biol Res. 2004;37:1707-1712. (Pubitemid 39549612)
32. Morewaya J, Koriyama C, Akiba S, et al. Epstein-Barr virusassociated gastric carcinoma in Papua New Guinea. Oncol Rep. 2004;12:1093-1098.
33. Ott G, Kirchner T, Muller-Hermelink HK. Monoclonal Epstein-Barr virus genomes but lack of EBV-related protein expression in different types of gastric carcinoma. Histopathology. 1994;25:323-329. (Pubitemid 24327127)
34. Yoshiwara E, Koriyama C, Akiba S, et al. Epstein-Barr virusassociated gastric carcinoma in Lima, Peru. J Exp Clin Cancer Res. 2005;24:49-54. (Pubitemid 40655862)
35. Anwar M, Koriyama C, Naveed IA, et al. Epstein-barr virus detection in tumors of upper gastrointestinal tract. An in situ hybridization study in Pakistan. J Exp Clin Cancer Res. 2005;24:379-385. (Pubitemid 41416122)
36. Chen JN, Ding YG, Feng ZY, et al. Association of distinctive Epstein-Barr virus variants with gastric carcinoma in Guangzhou, southern China. J Med Virol. 2010;82:658-667.
37. Burgess DE, Woodman CB, Flavell KJ, et al. Low prevalence of Epstein-Barr virus in incident gastric adenocarcinomas from the United Kingdom. Br J Cancer. 2002;86:702-704. (Pubitemid 34250809)
38. Trimeche M, Ksiaa F, Ziadi S, et al. Prevalence and characteristics of Epstein-Barr virus-associated gastric carcinomas in Tunisia. Eur J Gastroenterol Hepatol. 2009;21: 1001-1007.
39. Herrera-Goepfert R, Akiba S, Koriyama C, et al. Epstein-Barr virus-associated gastric carcinoma: evidence of age-dependence among a Mexican population. World J Gastroenterol. 2005;11:6096-6103. (Pubitemid 43085048)
40. Chang MS, Lee HS, Kim HS, et al. Epstein-Barr virus and microsatellite instability in gastric carcinogenesis. J Pathol. 2003;199:447-452. (Pubitemid 36411221)
41. Ojima H, Fukuda T, Nakajima T, et al. Discrepancy between clinical and pathological lymph node evaluation in Epstein-Barr virus-associated gastric cancers. Anticancer Res. 1996;16:3081-3084. (Pubitemid 26390252)
42. Murphy G, Pfeiffer R, Camargo MC, et al. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology. 2009;137:824-833.
43. Wakiguchi H. Overview of Epstein-Barr virus-associated diseases in Japan. Crit Rev Oncol Hematol. 2002;44:193-202. (Pubitemid 35435285)
44. Koriyama C, Akiba S, Minakami Y, et al. Environmental factors related to Epstein-Barr virus-associated gastric cancer in Japan. J Exp Clin Cancer Res. 2005;24:547-553. (Pubitemid 43139547)
45. Sinning C, Schaefer N, Standop J, et al. Gastric stump carcinoma-epidemiology and current concepts in pathogenesis and treatment. Eur J Surg Oncol. 2007;33:133-139. (Pubitemid 46336546)
46. Safatle-Ribeiro AV, Ribeiro U Jr., Reynolds JC. Gastric stump cancer: what is the risk? Dig Dis. 1998;16:159-168. (Pubitemid 128529228)
47. Yamamoto N, Tokunaga M, Uemura Y, et al. Epstein-Barr virus and gastric remnant cancer. Cancer. 1994;74:805-809. (Pubitemid 24237458)
48. Chang MS, Lee JH, Kim JP, et al. Microsatellite instability and Epstein-Barr virus infection in gastric remnant cancers. Pathol Int. 2000;50:486-492. (Pubitemid 30482394)
49. Baas IO, van Rees BP, Musler A, et al. Helicobacter pylori and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomach. J Clin Pathol. 1998;51:662-666. (Pubitemid 28423724)
50. Nishikawa J, Yanai H, Hirano A, et al. High prevalence of Epstein-Barr virus in gastric remnant carcinoma after Billroth-II reconstruction. Scand J Gastroenterol. 2002;37:825-829. (Pubitemid 34836820)
51. Chen JN, Jiang Y, Li HG, et al. Epstein-Barr virus genome polymorphisms of Epstein-Barr virus-associated gastric carcinoma in gastric remnant carcinoma in Guangzhou, southern China, an endemic area of nasopharyngeal carcinoma. Virus Res. 2011;160:191-199.
52. Kaizaki Y, Hosokawa O, Sakurai S, et al. Epstein-Barr virusassociated gastric carcinoma in the remnant stomach: de novo and metachronous gastric remnant carcinoma. J Gastroenterol. 2005;40:570-577. (Pubitemid 41038785)
53. Koriyama C, Akiba S, Corvalan A, et al. Histology-specific gender, age and tumor-location distributions of Epstein-Barr virus-associated gastric carcinoma in Japan. Oncol Rep. 2004; 12:543-547.
54. Nakamura S, Ueki T, Yao T, et al. Epstein-Barr virus in gastric carcinoma with lymphoid stroma. Special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis. Cancer. 1994;73:2239-2249. (Pubitemid 2080372)
55. Matsunou H, Konishi F, Hori H, et al. Characteristics of Epstein-Barr virus-associated gastric carcinoma with lymphoid stroma in Japan. Cancer. 1996;77:1998-2004. (Pubitemid 26142041)
56. Fukayama M. Epstein-Barr virus and gastric carcinoma. Pathol Int. 2010;60:337-350.
57. Maeda E, Akahane M, Uozaki H, et al. CT appearance of Epstein-Barr virus-associated gastric carcinoma. Abdom Imaging. 2009;34:618-625.
58. Arikawa J, Tokunaga M, Satoh E, et al. Morphological characteristics of Epstein-Barr virus-related early gastric carcinoma: a case-control study. Pathol Int. 1997;47:360-367. (Pubitemid 27274208)
59. Uemura Y, Tokunaga M, Arikawa J, et al. A unique morphology of Epstein-Barr virus-related early gastric carcinoma. Cancer Epidemiol Biomarkers Prev. 1994;3:607-611. (Pubitemid 24314450)
60. Tokunaga M, Land CE. Epstein-Barr virus involvement in gastric cancer: biomarker for lymph node metastasis. Cancer Epidemiol Biomarkers Prev. 1998;7:449-450. (Pubitemid 28354135)
61. Klein E. The complexity of the Epstein-Barr virus infection in humans. Pathol Oncol Res. 1998;4:3-7. (Pubitemid 28257189)
62. Brooks LA, Lear AL, Young LS, et al. Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency. J Virol. 1993;67:3182-3190. (Pubitemid 23143688)
63. Rowe M, Lear AL, Croom-Carter D, et al. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J Virol. 1992;66:122-131.
64. Young LS, Murray PG. Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene. 2003;22:5108-5121. (Pubitemid 37059592)
65. zur Hausen A, Brink AA, Craanen ME, et al. Unique transcription pattern of Epstein-Barr virus (EBV) in EBVcarrying gastric adenocarcinomas: expression of the transforming BARF1 gene. Cancer Res. 2000;60:2745-2748. (Pubitemid 30318253)
66. Sugiura M, Imai S, Tokunaga M, et al. Transcriptional analysis of Epstein-Barr virus gene expression in EBVpositive gastric carcinoma: unique viral latency in the tumour cells. Br J Cancer. 1996;74:625-631. (Pubitemid 26279061)
67. Luo B, Wang Y, Wang XF, et al. Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas. World J Gastroenterol. 2005;11:629-633. (Pubitemid 40220748)
68. Leight ER, Sugden B. EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus. RevMed Virol. 2000;10:83-100. (Pubitemid 30175424)
69. Yates JL, Warren N, Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature. 1985;313:812-815. (Pubitemid 15130835)
70. Sugden B, Warren N. A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J Virol. 1989;63:2644-2649. (Pubitemid 19137542)
71. Levitskaya J, Coram M, Levitsky V, et al. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-Nature. 1995;375:685-688.
72. Iwakiri D, Eizuru Y, Tokunaga M, et al. Autocrine growth of Epstein-Barr virus-positive gastric carcinoma cells mediated by an Epstein-Barr virus-encoded small RNA. Cancer Res. 2003;63:7062-7067. (Pubitemid 37413440)
73. Wang Q, Tsao SW, Ooka T, et al. Anti-apoptotic role of BARF1 in gastric cancer cells. Cancer Lett. 2006;238:90-103. (Pubitemid 43870244)
74. Fukuda M, Longnecker R. Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway. J Virol. 2004;78:1697-1705. (Pubitemid 38176702)
75. Hino R, Uozaki H, Inoue Y, et al. Survival advantage of EBVassociated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A. Cancer Res. 2008;68:1427-1435. (Pubitemid 351346850)
76. Hino R, Uozaki H, Murakami N, et al. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res. 2009;69:2766-2774.
77. Rowe M, Rowe DT, Gregory CD, et al. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitts lymphoma cells. EMBO J. 1987;6:2743-2751.
78. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281-297.
79. Pfeffer S, Zavolan M, Grasser FA, et al. Identification of virus-encoded microRNAs. Science. 2004;304:734-736. (Pubitemid 38560879)
80. Zhu JY, Pfuhl T, Motsch N, et al. Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J Virol. 2009;83:3333-3341.
81. Cai X, Schafer A, Lu S, et al. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2006;2:e23.
82. Kim do N, Chae HS, Oh ST, et al. Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Virol. 2007;81:1033-1036. (Pubitemid 46067928)
83. Lo AK, To KF, Lo KW, et al. Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc Natl Acad Sci USA. 2007;104:16164-16169. (Pubitemid 350099379)
84. Choy EY, Siu KL, Kok KH, et al. An Epstein-Barr virusencoded microRNA targets PUMA to promote host cell survival. J Exp Med. 2008;205:2551-2560.
85. Baer R, Bankier AT, Biggin MD, et al. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature. 1984;310:207-211. (Pubitemid 14090708)
86. McGeoch DJ, Gatherer D. Lineage structures in the genome sequences of three Epstein-Barr virus strains. Virology. 2007;359:1-5. (Pubitemid 46215706)
87. Zimber U, Adldinger HK, Lenoir GM, et al. Geographical prevalence of two types of Epstein-Barr virus. Virology. 1986;154:56-66. (Pubitemid 16015594)
88. Young LS, Yao QY, Rooney CM, et al. New type B isolates of Epstein-Barr virus from Burkitts lymphoma and from normal individuals in endemic areas. J Gen Virol. 1987;68(pt 11):2853-2862.
89. Fukayama M, Hayashi Y, Iwasaki Y, et al. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab Invest. 1994;71:73-81. (Pubitemid 24246024)
90. Lung ML, Chang RS, Huang ML, et al. Epstein-Barr virus genotypes associated with nasopharyngeal carcinoma in southern China. Virology. 1990;177:44-53. (Pubitemid 20218249)
91. Lung ML, Lam WP, Sham J, et al. Detection and prevalence of the "f" variant of Epstein-Barr virus in southern China. Virology. 1991;185:67-71.
92. Lung ML, Chang RS, Jones JH. Genetic polymorphism of natural Epstein-Barr virus isolates from infectious mononucleosis patients and healthy carriers. J Virol. 1988;62: 3862-3866.
93. Sidagis J, Ueno K, Tokunaga M, et al. Molecular epidemiology of Epstein-Barr virus (EBV) in EBV-related malignancies. Int J Cancer. 1997;72:72-76. (Pubitemid 27314642)
94. Abdel-Hamid M, Chen JJ, Constantine N, et al. EBV strain variation: geographical distribution and relation to disease state. Virology. 1992;190:168-175.
95. Corvalan A, Ding S, Koriyama C, et al. Association of a distinctive strain of Epstein-Barr virus with gastric cancer. Int J Cancer. 2006;118:1736-1742. (Pubitemid 43376437)
96. Kunimoto M, Tamura S, Tabata T, et al. One-step typing of Epstein-Barr virus by polymerase chain reaction: predominance of type 1 virus in Japan. J Gen Virol. 1992; 73(pt 2):455-461.
97. Khanim F, Yao QY, Niedobitek G, et al. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood. 1996;88:3491-3501. (Pubitemid 26365584)
98. Bhatia K, Raj A, Guitiérrez MI, et al. Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitts lymphomas. Oncogene. 1996;13:177-181. (Pubitemid 26248558)
99. Gutierrez MI, Raj A, Spangler G, et al. Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells. J Gen Virol. 1997;78(pt 7):1663-1670. (Pubitemid 27343106)
100. Chen YY, Chang KL, Chen WG, et al. Epstein-Barr virusassociated nuclear antigen-1 carboxy-terminal gene sequences in Japanese and American patients with gastric carcinoma. Lab Invest. 1998;78:877-882. (Pubitemid 28347884)
101. Wang Y, Liu X, Xing X, et al. Variations of Epstein-Barr virus nuclear antigen 1 gene in gastric carcinomas and nasopharyngeal carcinomas from Northern China. Virus Res. 2010;147:258-264.
102. Tanaka M, Kawaguchi Y, Yokofujita J, et al. Sequence variations of Epstein-Barr virus LMP2A gene in gastric carcinoma in Japan. Virus Genes. 1999;19:103-111. (Pubitemid 29469077)
103. Wang X, Liu X, Jia Y, et al. Widespread sequence variation in the Epstein-Barr virus latent membrane protein 2A gene among northern Chinese isolates. J Gen Virol. 2010;91: 2564-2573.
104. Wang Y, Zhang X, Chao Y, et al. New variations of Epstein-Barr virus-encoded small RNA genes in nasopharyngeal carcinomas, gastric carcinomas, and healthy donors in northern China. J Med Virol. 2010;82:829-836.
105. Zeng MS, Li DJ, Liu QL, et al. Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient. J Virol. 2005;79:15323-15330.
106. Li A, Zhang XS, Jiang JH, et al. Transcriptional expression of RPMS1 in nasopharyngeal carcinoma and its oncogenic potential. Cell Cycle. 2005;4:304-309. (Pubitemid 41365339)
107. Shimizu R, Yamamoto M. Gene expression regulation and domain function of hematopoietic GATA factors. Semin Cell Dev Biol. 2005;16:129-136. (Pubitemid 40126883)
108. zur Hausen A, van Grieken NC, Meijer GA, et al. Distinct chromosomal aberrations in Epstein-Barr virus-carrying gastric carcinomas tested by comparative genomic hybridization. Gastroenterology. 2001;121:612-618. (Pubitemid 32822576)
109. Chan WY, Liu Y, Li CY, et al. Recurrent genomic aberrations in gastric carcinomas associated with Helicobacter pylori and Epstein-Barr virus. Diagn Mol Pathol. 2002;11: 127-134.
110. van Rees BP, Caspers E, zur Hausen A, et al. Different pattern of allelic loss in Epstein-Barr virus-positive gastric cancer with emphasis on the p53 tumor suppressor pathway. Am J Pathol. 2002;161:1207-1213.
111. Chong JM, Fukayama M, Hayashi Y, et al. Microsatellite instability in the progression of gastric carcinoma. Cancer Res. 1994;54:4595-4597. (Pubitemid 24276478)
112. Leung SY, Yuen ST, Chung LP, et al. Microsatellite instability, Epstein-Barr virus, mutation of type II transforming growth factor beta receptor and BAX in gastric carcinomas in Hong Kong Chinese. Br J Cancer. 1999;79: 582-588. (Pubitemid 29046240)
113. Toyota M, Ahuja N, Suzuki H, et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res. 1999;59:5438-5442. (Pubitemid 29526452)
114. Kusano M, Toyota M, Suzuki H, et al. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus. Cancer. 2006;106:1467-1479.
115. Chang MS, Uozaki H, Chong JM, et al. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus. Clin Cancer Res. 2006;12: 2995-3002. (Pubitemid 43837343)
116. Enomoto S, Maekita T, Tsukamoto T, et al. Lack of association between CpG island methylator phenotype in human gastric cancers and methylation in their background non-cancerous gastric mucosae. Cancer Sci. 2007;98: 1853-1861. (Pubitemid 350002189)
117. Chong JM, Sakuma K, Sudo M, et al. Global and nonrandom CpG-island methylation in gastric carcinoma associated with Epstein-Barr virus. Cancer Sci. 2003;94:76-80. (Pubitemid 36575862)
118. Kang GH, Lee S, Cho NY, et al. DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis. Lab Invest. 2008;88:161-170. (Pubitemid 351161274)
119. Sakuma K, Chong JM, Sudo M, et al. High-density methylation of p14ARF and p16INK4A in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer. 2004;112:273-278. (Pubitemid 39244367)
120. Tsai CL, Li HP, Lu YJ, et al. Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling. Cancer Res. 2006;66:11668-11676.
121. Li H, Minarovits J. Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation. Adv Cancer Res. 2003;89:133-156. (Pubitemid 41184281)
122. Alazard N, Gruffat H, Hiriart E, et al. Differential hyperacetylation of histones H3 and H4 upon promoter-specific recruitment of EBNA2 in Epstein-Barr virus chromatin. J Virol. 2003;77:8166-8172. (Pubitemid 36792813)
123. Fejer G, Koroknai A, Banati F, et al. Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus. J Gen Virol. 2008;89: 1364-1370.
124. Oda K, Tamaru J, Takenouchi T, et al. Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma. Am J Pathol. 1993;143:1063-1071. (Pubitemid 24070549)
125. Saiki Y, Ohtani H, Naito Y, et al. Immunophenotypic characterization of Epstein-Barr virus-associated gastric carcinoma: massive infiltration by proliferating CD8+ T-lymphocytes. Lab Invest. 1996;75:67-76. (Pubitemid 26250274)
126. van Beek J, zur Hausen A, Snel SN, et al. Morphological evidence of an activated cytotoxic T-cell infiltrate in EBVpositive gastric carcinoma preventing lymph node metastases. Am J Surg Pathol. 2006;30:59-65. (Pubitemid 43740210)
127. Lee HS, Chang MS, Yang HK, et al. Epstein-barr viruspositive gastric carcinoma has a distinct protein expression profile in comparison with Epstein-Barr virus-negative carcinoma. Clin Cancer Res. 2004;10:1698-1705. (Pubitemid 38435561)
128. Kuzushima K, Nakamura S, Nakamura T, et al. Increased frequency of antigen-specific CD8(+) cytotoxic T lymphocytes infiltrating an Epstein-Barr virus-associated gastric carcinoma. J Clin Invest. 1999;104:163-171.
129. Niedobitek G, Herbst H, Young LS, et al. Epstein-Barr virus and carcinomas. Expression of the viral genome in an undifferentiated gastric carcinoma. Diagn Mol Pathol. 1992;1: 103-108.
130. Levitskaya J, Sharipo A, Leonchiks A, et al. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen Proc Natl Acad Sci USA. 1997;94:12616-12621. (Pubitemid 27492577)
131. Chong JM, Sakuma K, Sudo M, et al. Interleukin-1beta expression in human gastric carcinoma with Epstein-Barr virus infection. J Virol. 2002;76:6825-6831. (Pubitemid 34633548)
132. Ouburg S, Bart ACJ, Klinkenberg-Knol EC, et al. A candidate gene approach of immune mediators effecting the susceptibility to and severity of upper gastrointestinal tract diseases in relation to Helicobacter pylori and Epstein-Barr virus infections. Eur J Gastroenterol Hepatol. 2005;17:1213-1224. (Pubitemid 41527439)
133. Jung EJ, Lee YM, Lee BL, et al. Lytic induction and apoptosis of Epstein-Barr virus-associated gastric cancer cell line with epigenetic modifiers and ganciclovir. Cancer Lett. 2007;247:77-83. (Pubitemid 44959412)
134. Fu DX, Tanhehco Y, Chen J, et al. Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors. Nat Med. 2008;14:1118-1122.